Bay City Capital

Bay City Capital is a leading venture capital firm established in 1997, focusing on early-stage to growth equity investments in the life sciences sector. With a mission to drive innovation in healthcare, the firm has managed eight venture capital funds with over $1.6 billion in capital commitments and has invested in more than 100 companies globally. Bay City Capital is dedicated to advancing transformative biopharmaceutical investments across various geographies, including the United States, Canada, Western Europe, and China.